Department of Genomics and Proteomics, ACE Cells Lab Ltd, Rotherham, United Kingdom
Case Report
A Case Report: The First Show Phenomenon in the Treatment of Spinal Cord Injury with Regentime Procedure using Autologous Bone Marrow Derived Stem Cells
Author(s): Rita T. Boulos, Vanessa J. Mansour, Lea I. Nemer, Cynthia F. Najjoum, Elsa A. Asmar and Nassim H. Abi Chahine*
This case report demonstrates ‘the first show phenomenon’ following regentime stem cell therapy applied to a spinal
cord injury patient. A 40 years old gentleman sustained a ballistic injury at the level of T9, resulting in complete
bilateral motor and sensory loss from T9 and below. He was treated with autologous bone marrow derived
mononuclear stem cells injected into his spinal canal 2.5 years after his injury. Follow up during the first week post
transplantation showed early symptom improvement termed “the first show post phenomenon”. He regained
sensation to light touch in his lower limbs by the end of week 1 and reported no serious implications or
complications. .. View more»